Molecular analysis of primary and relapse isolates of Plasmodium vivax malaria

  • 2.36 MB
  • English
National Library of Canada , Ottawa
SeriesCanadian theses = -- Thèses canadiennes
The Physical Object
Pagination1 microfiche : negative. --
ID Numbers
Open LibraryOL16015582M
ISBN 100612126110

Abstract. Relapse infections are an important obstacle to the successful treatment and control of Plasmodium vivax malaria, but the molecular basis of relapse remains poorly understood. To provide insight into the molecular mechanisms of relapse, paired primary and relapse isolates of P.

vivax were subjected to single-strand conformational polymorphism (SSCP) and sequence analysis Cited by:   Plasmodium vivax has hepatocytic dormant stages, hypnozoites, that cause relapses. This work compared paired isolates from primary attacks and relapses obtained from 10 individuals in Brazil using the merozoite surface protein 1 gene, PvMSP1, as a genetic by: Craig AA, Kain KC.

Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infection. J Infect Dis. ; – Gogtay NJ, Desai S, Kadam VS, Kamtekar KD, Dalvi SS, Kshirsagar NA.

Relapse pattern of Plasmodium vivax in Mumbai: a study of cases of vivax malaria. J Assoc Phys India. ; –Cited by: 2. Molecular cloning and structure analysis of the gene encoding the Pv protein of the Sal-1 strain of Plasmodium vivax revealed an overall identity of % when the deduced amino acid sequence.

Download Molecular analysis of primary and relapse isolates of Plasmodium vivax malaria EPUB

Malaria in Nigeria is principally due to Plasmodium falciparum and, to a lesser extent to Plasmodium malariae and Plasmodium ovale. Plasmodium vivax is thought to be absent in Nigeria in particular and sub-Saharan Africa in general, due to the near fixation of the Duffy negative gene in this population.

Nevertheless, there are frequent reports of P. vivax infection in Duffy negative Cited by: Genetically unrelated P.

vivax parasites across primary and recurrent infections are thus compatible with both reinfection and relapse, e.g. parasites isolated from a relapse can be unrelated. Plasmodium vivax is the second most prevalent malaria parasite in the world, infecting >75 million people each year, predominantly in Asia and in Central and South America [1, 2].

vivax and Plasmodium ovale differ from Plasmodium falciparum in that they have a hypnozoite stage, which persists in the liver and causes relapses after clearance of the acute blood-stage infection.

Introduction: Relapses are important contributors to illness and morbidity in Plasmodium vivax and P. ovale infections. Relapse prevention (radical cure) with primaquine is required for optimal management, control and ultimately elimination of Plasmodium vivax malaria.

A review was conducted with publications in English, French, Portuguese and Spanish using the search terms ‘P. vivax’ and. Plasmodium vivax is a protozoal parasite and a human pathogen.

The most frequent and widely distributed cause of recurring (Benign tertian) malaria, P. vivax is one of the six species of malaria parasites that commonly infect humans.

It is less virulent than Plasmodium falciparum, the deadliest of the six, but vivax malaria can lead to severe. Plasmodium vivax is a major cause of febrile illness in endemic areas of Asia, Central and South America, and the horn of Africa.

Plasmodium vivax infections are characterized by relapses of malaria arising from persistent liver stages of the parasite (hypnozoites) which can be prevented only by 8-aminoquinoline anti-malarials.

Tropical P. vivax relapses at three week intervals if rapidly. Background. Plasmodium vivax is the most widely distributed human malaria parasite and accounts for approximately the same number of malaria cases as Plasmodium falciparum in India.

Compared with P. falciparum, P. vivax is difficult to eradicate because of its tendency to cause relapses, which impacts treatment and control strategies. The genetic diversity of these parasites, particularly of.

Laboratoy diagnosis of malaria. Plasmodium vivax. Schizonts. vivax. schizonts are large, have 12 to 24 merozoites, yellowish-brown, coalesced pigment, and may fill the rbc.

Schizont in a thick blood smear. Schizonts in thick blood smears. Immature schizont in. Introduction. Plasmodium vivax is a eukaryotic parasite that causes vivax malaria, a disease previously considered to be a benign form of malaria but now recognized to be associated with severe disease and responsible for considerable morbidity and mortality in endemic regions (Mueller et al., ; Kevin Baird, ).This parasite is widely distributed in tropical and temperate areas.

In southern Mexico, malaria transmission is low, seasonal, and persistent. Because many patients are affected by two or more malaria episodes caused by Plasmodium vivax, we carried out a study to determine the timing, frequency, and genetic identity of recurrent malaria episodes in the region between and Symptomatic patients with more than one P.

vivax infection were followed. The origin of renewed parasitaemia following a primary infection by Plasmodium vivax or Plasmodium ovale treated with a schizontocidal drug is either a recrudescence due to erythrocytic parasites that have survived treatment, a re-infection, or a relapse consequent to merozoites released from a dormant liver stage, the hypnozoite, that has activated to resume normal development.

CiteSeerX - Document Details (Isaac Councill, Lee Giles, Pradeep Teregowda): Abstract. A five-year epidemiologic study of patients attending a malaria clinic in Delhi was conducted to find the relapse rate of infections with Plasmodium vivax, its seasonal correlation between the primary infection and subsequent relapses, the duration of the incubation period, and the patterns of relapse.

Historically, P. vivax malaria has been called a “benign tertian malaria,” but this is a misnomer, given that recent studies have demonstrated severe and fatal pathologies associated with P.

vivax malaria [9, 10]. Relapses caused by the liver hypnozoites of this parasite can occur months or even several years after the primary attack. Dennis Shanks, in Advances in Parasitology, Plasmodium vivax represents a special challenge to malaria control because of the ability of a single infection to relapse over months to years.

vivax is more tolerant of low temperatures than P. falciparum, which spreads its potential range far beyond the tropics into sub-Arctic ry malaria control measures such as residual. Plasmodium vivax is the most widespread human malaria, and afflicts several hundred million people annually.

It is endemic to tropical and subtropical countries of the Americas, Africa, and Asia, including the Republic of Korea (ROK)[1–3].Unlike P. falciparum, P. vivax is characterized by hypnozoite relapse in the liver. After being bitten by a P.

vivax-infected mosquito, sporozoites enter. 2 Strategies for the control and elimination of P. vivax malaria 22 Vector control 22 Chemoprevention 25 Diagnosis of P. vivax infections 26 Diagnosis of G6PD deficiency 28 Treatment of uncomplicated P. vivax malaria 30 Treatment of severe P. vivax malaria 34 Drug resistance 36 Surveillance 38 3 Innovations needed The human malaria parasite Plasmodium vivax imposes unique challenges to its control and elimination.

Primary among those is the hypnozoite reservoir of infection in endemic communities. It is the dominant source of incident malaria and exceedingly difficult to attack due to both inability to diagnose latent carriers and the potentially life-threatening toxicity of primaquine in patients with.

worrisome [8], although the epidemiology and molecular mechanisms of resistance remain to be determined. Relapse of vivax malaria often confounds drug efficacy tests, since the relapse interval can coincide with the time when recrudescence of a drug resistant.

Plasmodium spp. DNA was detected in % (6/98) of the primates. vivax, and P. falciparum DNA was detected in % (2/98) and % (4/98) of these mammals, respectively. Sequencing and phylogenetic analysis confirmed the results obtained from the semi‐nested PCR.

2 Strategies for the control and elimination of P. vivax malaria 21 Vector control 21 Chemoprevention 24 Diagnosis of P. vivax infections 25 Diagnosis of G6PD de˜ciency 27 Treatment of uncomplicated P.

Description Molecular analysis of primary and relapse isolates of Plasmodium vivax malaria FB2

vivax malaria 29 Treatment of severe P. vivax malaria 33 Drug resistance 35 Surveillance 37 3 Innovations needed Background: Relapse of Plasmodium vivax infection is the main cause of vivax malaria in many parts of Asia.

However at the individual patient level, recurrence of a blood stage infection following treatment within the endemic area can be either a relapse (from dormant liver-stage parasites), a recrudescence (blood-stage treatment failure), or a reinfection (following a new mosquito inoculation).

Plasmodium vivax malaria is characterised by relapses after resolution of the primary infection which derive from activation of dormant liver stage parasites ‘hypnozoites’. It is this propensity to relapse, which makes P. vivax more difficult to control and eliminate than Plasmodium endemic areas, relapse of vivax malaria is a major cause of malaria in young children, and an.

A little guide for advanced search: Tip 1. You can use quotes "" to search for an exact expression. Example: "cell division" Tip 2.

You can use + symbol to restrict results containing all words.

Details Molecular analysis of primary and relapse isolates of Plasmodium vivax malaria EPUB

Example: +cell +stem Tip 3. You can use + and - symbols to force inclusion or exclusion of specific words. Example: +cell -stem. Trophozoites - Plasmodium falciparum: Early trophozoites have the characteristic signet ringunique to P.

falciparum is the presence of multiple trophozoites in one cell.: Trophozoites - Plasmodium vivax: Red blood cells infected by P. vivax are often larger than uninfected red blood cells. They approximately times the size of a normal cell.

Malaria is a mosquito‐borne disease caused by the Plasmodium parasite. Of the four Plasmodium species that routinely cause human malaria, Plasmodium vivax is the most widespread species outside Africa, causing ∼ million cases in P.

vivax cannot be cultured continuously in vitro, which severely hampers research in nonendemic and endemic countries alike. Causal Agent. Blood parasites of the genus are approximately named species of Plasmodium which infect various species of vertebrates.

Four species are considered true parasites of humans, as they utilize humans almost exclusively as a natural intermediate host: P.

falciparum, P. vivax, P. ovale and P. r, there are periodic reports of simian malaria parasites. We searched MEDLINE, Web of Science, Embase, and the Cochrane Database of Systematic Reviews with the terms “falciparum”, “vivax”, and “recurrence”, to identify all articles in any language published between Jan 1,and Jan 5,assessing the risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection.

A pooled analysis of individual patient data from.Plasmodium vivax is geographically the most widely distributed cause of malaria in people, with up to 25 billion people at risk and an estimated 80 million to million clinical cases every year—including severe disease and death.

Despite this large burden of disease, P vivax is overlooked and left in the shadow of the enormous problem caused by Plasmodium falciparum in sub-Saharan Africa.Relapse prevention (radical cure) with primaquine is required for optimal management, control and ultimately elimination of Plasmodium vivax malaria.

A review was conducted with publications in English, French, Portuguese and Spanish using the search terms 'P.

vivax' and 'relapse'.